Cyclo Therapeutics Inc (CYTH)

[curber]

This PR shows that the NPC treatment has gone international, I like the last line

NPC is one of at least 42 rare, fatal diseases which are classed as lysosomal storage diseases (LSD[color=red][/color]). The enormous medical interest generated by the ameliorative results as achieved in treating NPC has brought these other rare diseases into the limelight giving hope that they, too, can benefit from Cyclo(TM) use.